FDA Person
FDAChelsea W. Lamm
View detailed information about Chelsea W. Lamm, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 49 inspections of 45 companies, 2023–2026.
Inspections (49)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 11, 2026 | Steven H. Dayan, MD | Not classified | #1336198 | |
| July 31, 2026 | Northern Biomedical Research, Inc. | Not classified | Bioresearch Monitoring | #1324348 |
| June 25, 2026 | Bold Advanced Medical Future (BAMF) Health | Not classified | Bioresearch Monitoring | #1323458 |
| June 8, 2026 | MET Research, Inc. | Not classified | Bioresearch Monitoring | #1321122 |
| May 7, 2026 | Chloe A. Cunningham, FRACP, PhD | Not classified | #1318396 | |
| May 1, 2026 | Jane M. Zochling, FRACP, PhD | Not classified | Bioresearch Monitoring | #1314882 |
| April 22, 2026 | Meijer Distribution, Inc | Not classified | #1299458 | |
| March 12, 2026 | Western Michigan University Homer Stryker M.D. School of Medicine IRB | Not classified | #1307868 | |
| February 24, 2026 | Stephane Leung Wai Sang, MD | VAI | Product Evaluation: Medical Devices | #1304318 |
| January 9, 2026 | Peter C. Boldingh, Pharm.D | VAI | Bioresearch Monitoring | #1299058 |
| November 21, 2025 | TriApex Laboratories Co., Ltd. | Not classified | #1295494 | |
| November 14, 2025 | Guangdong Lewwin Pharmaceutical Research Institute | Not classified | #1293328 | |
| September 26, 2025 | Pharmaceutical Research Associates, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1283856 |
| September 12, 2025 | Rush University Medical Center IRB | Not classified | #1281798 | |
| August 8, 2025 | Indiana University IRB | Not classified | #1279195 | |
| July 11, 2025 | Center for Translational Medicine | VAI | Human Cellular, Tissue, and Gene Therapies | #1275411 |
| June 13, 2025 | Jena M. Krueger, M.D. | NAI | Bioresearch Monitoring | #1273493 |
| May 23, 2025 | Inotiv, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1270617 |
| May 1, 2025 | Scott A. Fretzin, M.D. | Not classified | #1269840 | |
| April 11, 2025 | Labcorp Early Development Laboratories, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1266550 |
Documents (24)
- 483 · Dawes Fretzin Clinical Research Group, Llc. · May 1, 2025
- 483 · TriApex Laboratories Co., Ltd · November 21, 2025
- 483 · Huilai Tianjin Zhang · February 21, 2025
- 483 · Northern Biomedical Research, Inc. · March 29, 2024
- 483 · TriApex Laboratories Co., Ltd. · November 21, 2025
- 483 · Center for Translational Medicine · July 11, 2025
- 483 · Inotiv, Inc. · May 23, 2025
- 483 · Scott A. Fretzin, M.D. · May 1, 2025
- 483 · Labcorp Early Development Laboratories, Inc. · April 11, 2025
- 483 · Pharmaceutical Research Associates, Inc. · September 26, 2025
- 483 · EUROFINS ANIMAL HEALTH TESTING · November 8, 2024
- EIR · Greenfield Pathology Services, Inc. · September 13, 2023
- 483 · Steven H. Dayan, MD · October 6, 2023
- 483 · Huilai Zhang, MD · August 12, 2022
- 483 · Veronique Sebastian, M.D. · May 25, 2023
- 483 · Nehal J. Lakhani, M.D. · November 17, 2023
- 483 · Rush University Medical Center IRB · September 12, 2025
- 483 · Dennis Hammond · June 20, 2023
- 483 · Labcorp Early Development Laboratories, Inc. · July 12, 2024
- 483 · Stephane Leung Wai Sang, MD · February 24, 2026
- 483 · Jane M. Zochling, FRACP, PhD · May 1, 2026
- 483 · Bold Advanced Medical Future (BAMF) Health · June 25, 2026
- 483 · MET Research, Inc. · June 8, 2026
- 483 · Northern Biomedical Research, Inc. · July 31, 2026
Frequently inspected with (10)
Corrine M. Carter
investigator
11 shared
Dina A. Tallman
investigator
5 shared
Victoria R. Flournoy
3 shared
Andrew R. Wasko
2 shared
Stephen O. Agyemang
2 shared
Daniel B Bordt
1 shared
Eric S. Pittman
Director, Bioresearch Monitoring Division (West) and FDA Delegate to the OECD Working Party on GLPs
1 shared
Jennifer A. Kemp
issuing_officer
1 shared
L'Oreal F. Walker
1 shared
Veronica L. Bush
1 shared
Person Information
Name
Chelsea W. Lamm
Title
investigator
Role
COMPANY REP
ID: d7a8dd67-dc26-4c8a-8e3c-aebc267cb775
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.